Breaking News

OctoPlus In Drug Development Pact with Ferring

To provide formulation development and manufacturing services

OctoPlus N.V. has entered into a formulation development and manufacturing contract with Ferring Pharmaceuticals for an undisclosed compound. Financial details were not disclosed.

OctoPlus provides formulation development and clinical material manufacturing services to pharma and biopharma companies and offers drug delivery technologies for the development of controlled release versions of new or existing drugs.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters